{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T15:33:45Z","timestamp":1789832025211,"version":"4.0.1"},"reference-count":11,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,22]],"date-time":"2023-12-22T00:00:00Z","timestamp":1703203200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine Case Reports"],"published-print":{"date-parts":[[2024]]},"DOI":"10.1016\/j.rmcr.2023.101974","type":"journal-article","created":{"date-parts":[[2023,12,23]],"date-time":"2023-12-23T17:04:41Z","timestamp":1703351081000},"page":"101974","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Efficacy of durvalumab plus chemotherapy in small-cell lung cancer with Lambert-Eaton myasthenic syndrome"],"prefix":"10.1016","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-8587-0439","authenticated-orcid":false,"given":"Naoya","family":"Ishibashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiharu","family":"Tabata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Nonomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Oshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanobu","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Mitomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takafumi","family":"Sugawara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motoyasu","family":"Sagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.rmcr.2023.101974_bib1","doi-asserted-by":"crossref","first-page":"a003947","DOI":"10.1101\/cshperspect.a003947","article-title":"Voltage-gated calcium channels","volume":"3","author":"Catterall","year":"2011","journal-title":"Cold Spring Harbor Perspect. Biol."},{"issue":"4","key":"10.1016\/j.rmcr.2023.101974_bib2","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.bbrc.2004.08.040","article-title":"Lambert-Eaton myasthenic syndrome as an autoimmune calcium channelopathy","volume":"322","author":"Takamori","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"10212","key":"10.1016\/j.rmcr.2023.101974_bib3","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1016\/S0140-6736(19)32222-6","article-title":"Durvalumab plus platinum-etoposide versus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial","volume":"394","author":"Paz-Ares","year":"2019","journal-title":"Lancet"},{"issue":"23","key":"10.1016\/j.rmcr.2023.101974_bib4","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1056\/NEJMoa1809064","article-title":"First-Line atezolizumab plus chemotherapy in extensive-stage small-cell lung cancer","volume":"379","author":"Horn","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.rmcr.2023.101974_bib5","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1002\/art.41068","article-title":"Safety and efficacy of immune checkpoint inhibitors in patients with cancer and preexisting autoimmune disease: a nationwide, multicenter cohort study","volume":"71","author":"Tison","year":"2019","journal-title":"Arthritis Rheumatol."},{"issue":"10","key":"10.1016\/j.rmcr.2023.101974_bib6","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1212\/WNL.40.10.1552","article-title":"Response of the Lambert-Eaton myasthenic syndrome to treatment of associated small-cell lung carcinoma","volume":"40","author":"Chalk","year":"1990","journal-title":"Neurology"},{"key":"10.1016\/j.rmcr.2023.101974_bib7","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s42466-020-00099-5","article-title":"Immunoglobulins to mitigate paraneoplastic Lambert Eaton Myasthenic Syndrome under checkpoint inhibition in Merkel cell carcinoma","volume":"2","author":"Dohrn","year":"2020","journal-title":"Neurol Res Pract"},{"issue":"5","key":"10.1016\/j.rmcr.2023.101974_bib8","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3892\/ol.2022.13513","article-title":"Combined treatment with radiotherapy, chemotherapy and avelumab results in regression of metastatic Merkel cell carcinoma and improvement of associated Lambert-Eaton myasthenic syndrome: a case report","volume":"24","author":"Green","year":"2022","journal-title":"Oncol. Lett."},{"issue":"7","key":"10.1016\/j.rmcr.2023.101974_bib9","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.2169\/internalmedicine.0072-22","article-title":"Lambert-eaton myasthenic syndrome recurrence induced by pembrolizumab in a patient with non-small-cell lung cancer","volume":"62","author":"Takigawa","year":"2023","journal-title":"Intern. Med."},{"issue":"3","key":"10.1016\/j.rmcr.2023.101974_bib10","doi-asserted-by":"crossref","first-page":"e273","DOI":"10.1016\/j.cllc.2021.09.001","article-title":"An extensive-stage small-cell lung cancer case with preexisting lambert-eaton myasthenic syndrome successfully treated with an immune checkpoint inhibitor","volume":"23","author":"Sakaguchi","year":"2022","journal-title":"Clin. Lung Cancer"},{"issue":"2","key":"10.1016\/j.rmcr.2023.101974_bib11","doi-asserted-by":"crossref","first-page":"71","DOI":"10.14740\/jmc4043","article-title":"Durvalumab for extensive-stage of small-cell lung cancer with lambert-eaton myasthenic syndrome","volume":"14","author":"Machiyama","year":"2023","journal-title":"J. Med. Cases"}],"container-title":["Respiratory Medicine Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213007123001697?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213007123001697?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,10]],"date-time":"2024-08-10T19:15:17Z","timestamp":1723317317000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213007123001697"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":11,"alternative-id":["S2213007123001697"],"URL":"https:\/\/doi.org\/10.1016\/j.rmcr.2023.101974","relation":{},"ISSN":["2213-0071"],"issn-type":[{"value":"2213-0071","type":"print"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of durvalumab plus chemotherapy in small-cell lung cancer with Lambert-Eaton myasthenic syndrome","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmcr.2023.101974","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101974"}}